1. Home
  2. SFWL vs FLNA Comparison

SFWL vs FLNA Comparison

Compare SFWL & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shengfeng Development Limited

SFWL

Shengfeng Development Limited

HOLD

Current Price

$0.89

Market Cap

72.7M

Sector

Industrials

ML Signal

HOLD

FLNA

Filana Therapeutics Inc. Common Stock

N/A

Current Price

$0.81

Market Cap

61.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SFWL
FLNA
Founded
2001
1998
Country
China
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.7M
61.8M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
SFWL
FLNA
Price
$0.89
$0.81
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.3K
251.9K
Earning Date
03-27-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$41,119,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.56
$0.82
52 Week High
$1.27
$2.03

Technical Indicators

Market Signals
Indicator
SFWL
FLNA
Relative Strength Index (RSI) 53.32 33.69
Support Level $0.84 N/A
Resistance Level $1.04 $0.99
Average True Range (ATR) 0.07 0.05
MACD 0.00 -0.00
Stochastic Oscillator 67.61 7.54

Price Performance

Historical Comparison
SFWL
FLNA

About SFWL Shengfeng Development Limited

Shengfeng Development Ltd is a holding company. Through its subsidiaries, it offers contract logistics services in China. The contract logistics services offered by the company include planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services. The company's operations are based in the PRC. Its integrated logistics solutions are comprised of three business streams: B2B freight transportation services; cloud storage services; and value-added services. The company derives maximum revenue from Transportation, followed by Warehouse storage management services. The solutions provides by the company are : Internet TV; Electronic communication; Textiles and Apparel; Automotive parts; and e-commerce.

About FLNA Filana Therapeutics Inc. Common Stock

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Share on Social Networks: